Yet another piece of bad news showed up--without mainstream coverage--in the health news this week. A long term study of Actos discovered that there is a clear dose and time-related increase in bladder cancer among those who take it. As MedPage Today reports:An interim analysis of data from the study, which includes more than 193,000 patients with type 2 diabetes, revealed no statistically significant increase in bladder cancer among pioglitazone users compared with nonusers (hazard ratio 1.2, 9
Diabetic Cake Recipes ...
No comments:
Post a Comment